Page last updated: 2024-08-22

n-methylaspartate and ci 988

n-methylaspartate has been researched along with ci 988 in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Little, HJ; Wilson, J1
Bradley, EL; Bright, CA; Kissin, I1

Other Studies

2 other study(ies) available for n-methylaspartate and ci 988

ArticleYear
CCK(B) antagonists protect against some aspects of the ethanol withdrawal syndrome.
    Pharmacology, biochemistry, and behavior, 1998, Volume: 59, Issue:4

    Topics: Acoustic Stimulation; Alcoholism; Animals; Anti-Anxiety Agents; Behavior, Animal; Central Nervous System Depressants; Dipeptides; Ethanol; Excitatory Amino Acid Agonists; Handling, Psychological; Indoles; Male; Meglumine; Mice; Mice, Inbred Strains; N-Methylaspartate; Receptors, Cholecystokinin; Seizures; Substance Withdrawal Syndrome

1998
Acute tolerance to continuously infused alfentanil: the role of cholecystokinin and N-methyl-D-aspartate-nitric oxide systems.
    Anesthesia and analgesia, 2000, Volume: 91, Issue:1

    Topics: Alfentanil; Analgesia; Analgesics, Opioid; Animals; Benzodiazepinones; Cholecystokinin; Dizocilpine Maleate; Drug Tolerance; Indoles; Infusions, Intravenous; Male; Meglumine; N-Methylaspartate; NG-Nitroarginine Methyl Ester; Nitric Oxide; Pain Threshold; Phenylurea Compounds; Proglumide; Rats; Rats, Sprague-Dawley; Receptors, Cholecystokinin

2000